AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
11.17
+0.87 (8.45%)
At close: Nov 4, 2024, 4:00 PM
11.10
-0.07 (-0.63%)
After-hours: Nov 4, 2024, 6:02 PM EST
AVITA Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Net Income | -49.83 | -35.38 | -26.67 | -25.14 | -26.58 | -42.03 | Upgrade
|
| Depreciation & Amortization | 0.76 | 0.63 | 0.57 | 0.67 | 0.72 | 0.47 | Upgrade
|
| Other Amortization | 0.17 | 0.34 | 0.34 | 0.3 | 0.13 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.09 | 0.08 | 0 | 0.13 | 0.13 | 0.26 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.02 | 0 | - | 0.04 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -1.9 | -1.36 | -0.28 | 0.1 | - | - | Upgrade
|
| Stock-Based Compensation | 11.22 | 8.38 | 7 | 6.33 | 5.66 | 16.59 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.09 | 0.02 | -0.01 | 0.02 | 0.01 | 0.04 | Upgrade
|
| Other Operating Activities | -4.72 | -4.16 | 1.15 | 0.93 | 1.39 | 0.59 | Upgrade
|
| Change in Accounts Receivable | -2.88 | -4.17 | -0.4 | -1.19 | -1.4 | -0.73 | Upgrade
|
| Change in Inventory | -4.04 | -3.69 | -0.37 | -0.14 | -0.75 | -0.47 | Upgrade
|
| Change in Accounts Payable | -1.34 | 0.81 | 0.28 | -0.05 | -1.33 | 2.31 | Upgrade
|
| Change in Unearned Revenue | -0.03 | -0.34 | -0.25 | 0.36 | 0.64 | 0.01 | Upgrade
|
| Change in Other Net Operating Assets | -0.92 | 0.82 | -0.46 | -0.39 | -4.52 | 0.09 | Upgrade
|
| Operating Cash Flow | -53.48 | -38.01 | -19.09 | -18.04 | -25.9 | -22.75 | Upgrade
|
| Capital Expenditures | -4.6 | -1.38 | -0.45 | -0.49 | -0.89 | -0.59 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.13 | -0.07 | -0.07 | -0.17 | -0.28 | -0.26 | Upgrade
|
| Investment in Securities | -3.32 | 3.05 | -18.81 | -49.55 | - | - | Upgrade
|
| Investing Cash Flow | -8.05 | 1.61 | -19.33 | -50.21 | -1.17 | -0.85 | Upgrade
|
| Long-Term Debt Issued | - | 38.76 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | -0.01 | -0.04 | Upgrade
|
| Total Debt Repaid | - | - | - | -0 | -0.01 | -0.04 | Upgrade
|
| Net Debt Issued (Repaid) | 38.76 | 38.76 | - | -0 | -0.01 | -0.04 | Upgrade
|
| Issuance of Common Stock | 2.75 | 1.61 | 0.9 | 69.18 | 69.17 | 82.18 | Upgrade
|
| Other Financing Activities | - | - | - | -5.11 | -5.11 | -5.08 | Upgrade
|
| Financing Cash Flow | 41.51 | 40.37 | 0.9 | 64.07 | 64.05 | 77.06 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.02 | -0.02 | -0.03 | -0.07 | 0.13 | 0 | Upgrade
|
| Net Cash Flow | -20.03 | 3.95 | -37.55 | -4.25 | 37.11 | 53.47 | Upgrade
|
| Free Cash Flow | -58.08 | -39.39 | -19.54 | -18.52 | -26.8 | -23.34 | Upgrade
|
| Free Cash Flow Margin | -107.28% | -78.56% | -56.77% | -56.09% | -91.66% | -163.62% | Upgrade
|
| Free Cash Flow Per Share | -2.27 | -1.56 | -0.78 | -0.76 | -1.18 | -1.15 | Upgrade
|
| Cash Interest Paid | 3.84 | 1.14 | 0.02 | 0.03 | 0 | 0.04 | Upgrade
|
| Cash Income Tax Paid | 0.02 | 0.04 | 0.02 | 0.01 | 0.04 | - | Upgrade
|
| Levered Free Cash Flow | -36.56 | -24.02 | -9.31 | - | -17.59 | -8.59 | Upgrade
|
| Unlevered Free Cash Flow | -34.16 | -23.31 | -9.3 | - | -17.58 | -8.57 | Upgrade
|
| Change in Net Working Capital | 7.64 | 4.61 | -0.51 | - | 6.32 | -1.9 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.